Activity-based reporter assays for the screening of abused substances in biological matrices

References

• Abouchedid R, Hudson S, Thurtle N, Yamamoto T, Ho JH, Bailey G, Wood M, Sadones N, Stove CP, Dines A. 2017. Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015. Clin Toxicol (Phila). 55:338–345.
   PubMed Web of Science ®Google Scholar
• Armenian P, Vo KT, Barr-Walker J, Lynch KL. 2017. Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review. Neuropharmacology. 134:121–132.
   PubMed Web of Science ®Google Scholar
• Atwood BK, Huffman J, Straiker A, Mackie K. 2010. JWH018, a common constituent of ‘Spice’ herbal blends, is a potent and efficacious cannabinoid CB receptor agonist. Br J Pharmacol. 160:585–593.
   PubMed Web of Science ®Google Scholar
• Atwood BK, Lee D, Straiker A, Widlanski TS, Mackie K. 2011. CP47,497-C8 and JWH073, commonly found in ‘Spice’ herbal blends, are potent and efficacious CB(1) cannabinoid receptor agonists. Eur J Pharmacol. 659:139–145.
   PubMed Web of Science ®Google Scholar
• Auwärter V, Dresen S, Weinmann W, Müller M, Pütz M, Ferreiros N. 2009. ‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom. 44:832–837.
   PubMed Web of Science ®Google Scholar
• Bailey K, Yazdi T, Masharani U, Tyrrell B, Butch A, Schaufele F. 2016. Advantages and limitations of androgen receptor-based methods for detecting anabolic androgenic steroid abuse as performance enhancing drugs. PLoS One. 11:e0151860.
   PubMed Web of Science ®Google Scholar
• Banister SD, Moir M, Stuart J, Kevin RC, Wood KE, Longworth M, Wilkinson SM, Beinat C, Buchanan AS, Glass M, et al. 2015. Pharmacology of indole and indazole synthetic cannabinoid designer drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA. ACS Chem Neurosci. 6:1546–1559.
   PubMed Web of Science ®Google Scholar
• Banister SD, Stuart J, Kevin RC, Edington A, Longworth M, Wilkinson SM, Beinat C, Buchanan AS, Hibbs DE, Glass M, et al. 2015. Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135. ACS Chem Neurosci. 6:1445–1458.
   PubMed Web of Science ®Google Scholar
• Battista N, Pasquariello N, Di Tommaso M, Maccarrone M. 2008. Interplay between endocannabinoids, steroids and cytokines in the control of human reproduction. J Neuroendocrinol. 20:82–89.
   PubMed Web of Science ®Google Scholar
• Becue I. 2012. Development of an untargeted screening strategy for tracing steroid hormones. Ghent (Belgium): Ghent University.
   Google Scholar
• Blankvoort BM, Aarts JM, Schilt R, Geerdink P, Spenkelink B, Rodenburg RJ. 2003. Detection of hormonal anabolic compounds in calf urine and unverified growth-promoting preparations: application of the AR-LUX bioassay for screening and determination of androgenic activity. Analyst. 128:1373–1381.
   PubMed Web of Science ®Google Scholar
• Bovee TF, Bor G, Heskamp HH, Lasaroms JJ, Sanders MB, Nielen MW. 2009. Validation and application of a yeast bioassay for screening androgenic activity in calf urine and feed. Anal Chim Acta. 637:225–234.
   PubMed Web of Science ®Google Scholar
• Bovee TF, Helsdingen RJ, Hamers AR, van Duursen MB, Nielen MW, Hoogenboom RL. 2007. A new highly specific and robust yeast androgen bioassay for the detection of agonists and antagonists. Anal Bioanal Chem. 389:1549–1558.
   PubMed Web of Science ®Google Scholar
• Bovee TF, Helsdingen RJ, Koks PD, Kuiper HA, Hoogenboom RL, Keijer J. 2004. Development of a rapid yeast estrogen bioassay, based on the expression of green fluorescent protein. Gene. 325:187–200.
   PubMed Web of Science ®Google Scholar
• Bovee TF, Heskamp HH, Hamers ARM, Hoogenboom RLAP, Nielen MWF. 2005. Validation of a rapid yeast estrogen bioassay, based on the expression of green fluorescent protein, for the screening of estrogenic activity in calf urine. Anal Chim Acta. 529:57–64.
   Web of Science ®Google Scholar
• Bovee TF, Pikkemaat MG. 2009. Bioactivity-based screening of antibiotics and hormones. J Chromatogr A. 1216:8035–8050.
   PubMed Web of Science ®Google Scholar
• Brents LK, Gallus-Zawada A, Radominska-Pandya A, Vasiljevik T, Prisinzano TE, Fantegrossi WE, Moran JH, Prather PL. 2012. Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity. Biochem Pharmacol. 83:952–961.
   PubMed Web of Science ®Google Scholar
• Brents LK, Reichard EE, Zimmerman SM, Moran JH, Fantegrossi WE, Prather PL. 2011. Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PLoS One. 6:e21917.
   PubMed Web of Science ®Google Scholar
• Burdge GC, Coldham NG, Dave M, Sauer MJ, Bleach EC. 1998. Determination of oestrogen concentrations in bovine plasma by a recombinant oestrogen receptor–reporter gene yeast bioassay. Analyst. 123:2585–2588.
   PubMed Web of Science ®Google Scholar
• Cadwallader AB, Lim CS, Rollins DE, Botre F. 2011. The androgen receptor and its use in biological assays: looking toward effect-based testing and its applications. J Anal Toxicol. 35:594–607.
   PubMed Web of Science ®Google Scholar
• Campana C, Pezzi V, Rainey WE. 2015. Cell-based assays for screening androgen receptor ligands. Semin Reprod Med. 33:225–234.
   PubMed Web of Science ®Google Scholar
• Cannaert A, Ambach L, Blanckaert P, Stove CP. 2018a. Activity-based detection and bioanalytical confirmation of a fatal carfentanil intoxication. Front Pharmacol. 9:486.
   PubMed Web of Science ®Google Scholar
• Cannaert A, Franz F, Auwarter V, Stove CP. 2017. Activity-based detection of consumption of synthetic cannabinoids in authentic urine samples using a stable cannabinoid reporter system. Anal Chem. 89:9527–9536.
   PubMed Web of Science ®Google Scholar
• Cannaert A, Storme J, Franz F, Auwarter V, Stove CP. 2016. Detection and activity profiling of synthetic cannabinoids and their metabolites with a newly developed bioassay. Anal Chem. 88:11476–11485.
   PubMed Web of Science ®Google Scholar
• Cannaert A, Storme J, Hess C, Auwaerter V, Wille SM, Stove CP. 2018b. Activity-based detection of cannabinoids in serum and plasma samples. Clin Chem. 64:918–926.
   PubMed Web of Science ®Google Scholar
• Cannaert A, Vandeputte M, Hudson S, Wood DM, Dargan PI, Stove CP. 2019. Validation of activity-based screening for synthetic cannabinoid receptor agonists in a large set of serum samples. Clin Chem. 65:347–349.
   PubMed Web of Science ®Google Scholar
• Cannaert A, Vasudevan L, Friscia M, Mohr ALA, Wille SMR, Stove CP. 2018c. Activity-based concept to screen biological matrices for opiates and (synthetic) opioids. Clin Chem. 64:1221–1229.
   PubMed Web of Science ®Google Scholar
• Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. 2014. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend. 144:12–41.
   PubMed Web of Science ®Google Scholar
• Cauchon D. 2018. Fentanyl-laced cocaine is Ohio’s newest killer – but we can combat this scourge: Dennis Cauchon (Opinion). http://wwwclevelandcom/opinion/indexssf/2018/01/cocaine_mixed_with_fentanyl_ishtml.
   Google Scholar
• Cevenini L, Michelini E, D’Elia M, Guardigli M, Roda A. 2013. Dual-color bioluminescent bioreporter for forensic analysis: evidence of androgenic and anti-androgenic activity of illicit drugs. Anal Bioanal Chem. 405:1035–1045.
   PubMed Web of Science ®Google Scholar
• Chamas A, Pham HTM, Jahne M, Hettwer K, Uhlig S, Simon K, Einspanier A, Baronian K, Kunze G. 2017. Simultaneous detection of three sex steroid hormone classes using a novel yeast-based biosensor. Biotechnol Bioeng. 114:1539–1549.
   PubMed Web of Science ®Google Scholar
• Chimalakonda KC, Seely KA, Bratton SM, Brents LK, Moran CL, Endres GW, James LP, Hollenberg PF, Prather PL, Radominska-Pandya A, et al. 2012. Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/spice: identification of novel cannabinoid receptor ligands. Drug Metab Dispos. 40:2174–2184.
   PubMed Web of Science ®Google Scholar
• Connolly L, Cai K, Van der Heiden E, Scippo ML, Muller M, Tarbin J, Elliott C. 2009. Detection of glucocorticoid bioactivity in bovine urine samples using a reporter gene assay. Anal Chim Acta. 637:321–327.
   PubMed Web of Science ®Google Scholar
• Cooper ER. 2013. The use of bioassays to detect designer androgens in sports supplements. Sydney (Australia): University of Technology Sydney.
   Google Scholar
• De Marchi N, De Petrocellis L, Orlando P, Daniele F, Fezza F, Di Marzo V. 2003. Endocannabinoid signalling in the blood of patients with schizophrenia. Lipids Health Dis. 2:5.
   PubMedGoogle Scholar
• Divari S, De Maria R, Cannizzo FT, Spada F, Mulasso C, Bovee TF, Capra P, Leporati M, Biolatti B. 2010. A RIKILT yeast estrogen bioassay (REA) for estrogen residue detection in urine of calves experimentally treated with 17beta-estradiol. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 27:19–28.
   PubMed Web of Science ®Google Scholar
• Dixon AS, Schwinn MK, Hall MP, Zimmerman K, Otto P, Lubben TH, Butler BL, Binkowski BF, Machleidt T, Kirkland TA, et al. 2016. NanoLuc complementation reporter optimized for accurate measurement of protein interactions in cells. ACS Chem Biol. 11:400–408.
   PubMed Web of Science ®Google Scholar
• Ekstrom L, Cevenini L, Michelini E, Schulze J, Thorngren JO, Belanger A, Guillemette C, Garle M, Roda A, Rane A. 2013. Testosterone challenge and androgen receptor activity in relation to UGT2B17 genotypes. Eur J Clin Invest. 43:248–255.
   PubMed Web of Science ®Google Scholar
• EMCDDA. 2015. New psychoactive substances in Europe: an update of the EU Early Warning System. Luxembourg: Publications Office.
   Google Scholar
• EMCDDA. 2018. European drug report: trends and developments. Luxembourg: Publications Office
   Google Scholar
• Engeli S, Bohnke J, Feldpausch M, Gorzelniak K, Janke J, Batkai S, Pacher P, Harvey-White J, Luft FC, Sharma AM, et al. 2005. Activation of the peripheral endocannabinoid system in human obesity. Diabetes. 54:2838–2843.
   PubMed Web of Science ®Google Scholar
• Ernst R, Klemm R, Schmitt L, Kuchler K. 2005. Yeast ATP-binding cassette transporters: cellular cleaning pumps. Methods Enzymol. 400:460–484.
   PubMed Web of Science ®Google Scholar
• Fantegrossi WE, Moran JH, Radominska-Pandya A, Prather PL. 2014. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Delta(9)-THC: mechanism underlying greater toxicity? Life Sci. 97:45–54.
   PubMed Web of Science ®Google Scholar
• Feasel MG. 2017. The use of in vitro and in silico technologies for predicting human pharmacology and toxicology of Carfentanil. Baltimore (MD): University of Maryland.
   Google Scholar
• Ford BM, Tai S, Fantegrossi WE, Prather PL. 2017. Synthetic pot: not your grandfather’s Marijuana. Trends Pharmacol Sci. 38:257–276.
   PubMed Web of Science ®Google Scholar
• Franz F, Angerer V, Jechle H, Pegoro M, Ertl H, Weinfurtner G, Janele D, Schlogl C, Friedl M, Gerl S, et al. 2017. Immunoassay screening in urine for synthetic cannabinoids – an evaluation of the diagnostic efficiency. Clin Chem Lab Med. 55:1375–1384.
   PubMed Web of Science ®Google Scholar
• Gaido KW, Leonard LS, Lovell S, Gould JC, Babai D, Portier CJ, McDonnell DP. 1997. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol Appl Pharmacol. 143:205–212.
   PubMed Web of Science ®Google Scholar
• Gerlach T, Knaust J, Kaiser C, Korner M, Hettwer K, Uhlig S, Simon K, Baronian K, Kunze G. 2014. Development and assessment of a novel Arxula adeninivorans androgen screen (A-YAS) assay and its application in analysis of cattle urine. Sci Total Environ. 490:1073–1081.
   PubMed Web of Science ®Google Scholar
• Guerrieri D, Kjellqvist F, Kronstrand R, Green H. 2018. Validation and cross-reactivity data for fentanyl analogs with the immunalysis fentanyl ELISA. J Anal Toxicol. 43:18–24.
   Web of Science ®Google Scholar
• Handelsman DJ. 2008. Indirect androgen doping by oestrogen blockade in sports. Br J Pharmacol. 154:598–605.
   PubMed Web of Science ®Google Scholar
• Handelsman DJ, Heather A. 2008. Androgen abuse in sports. Asian J Androl. 10:403–415.
   PubMed Web of Science ®Google Scholar
• Hermanns-Clausen M, Kneisel S, Szabo B, Auwärter V. 2013. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction. 108:534–544.
   PubMed Web of Science ®Google Scholar
• Hero M, Janne OA, Nanto-Salonen K, Dunkel L, Raivio T. 2005. Circulating antiandrogenic activity in children with congenital adrenal hyperplasia during peroral flutamide treatment. J Clin Endocrinol Metab. 90:5141–5145.
   PubMed Web of Science ®Google Scholar
• Heyman E, Gamelin FX, Goekint M, Piscitelli F, Roelands B, Leclair E, Di Marzo V, Meeusen R. 2012. Intense exercise increases circulating endocannabinoid and BDNF levels in humans-possible implications for reward and depression. Psychoneuroendocrinology. 37:844–851.
   PubMed Web of Science ®Google Scholar
• Houtman CJ, Sterk SS, van de Heijning MP, Brouwer A, Stephany RW, van der Burg B, Sonneveld E. 2009. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays. Anal Chim Acta. 637:247–258.
   PubMed Web of Science ®Google Scholar
• Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, et al. 2002. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev. 54:161–202.
   PubMed Web of Science ®Google Scholar
• Jaatinen S, Kivisto A, Palmroth MR, Karp M. 2016. Effect of source-separated urine storage on estrogenic activity detected using bioluminescent yeast Saccharomyces cerevisiae. Environ Technol. 37:2172–2182.
   PubMed Web of Science ®Google Scholar
• Kaiser C, Uhlig S, Gerlach T, Korner M, Simon K, Kunath K, Florschutz K, Baronian K, Kunze G. 2010. Evaluation and validation of a novel Arxula adeninivorans estrogen screen (nAES) assay and its application in analysis of wastewater, seawater, brackish water and urine. Sci Total Environ. 408:6017–6026.
   PubMed Web of Science ®Google Scholar
• Kazlauskas R. 2010. Designer steroids. Handb Exp Pharmacol. (195):155–185.
   Google Scholar
• Klein KO, Baron J, Colli MJ, McDonnell DP, Cutler GB Jr. 1994. Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J Clin Invest. 94:2475–2480.
   PubMed Web of Science ®Google Scholar
• Leskinen P, Michelini E, Picard D, Karp M, Virta M. 2005. Bioluminescent yeast assays for detecting estrogenic and androgenic activity in different matrices. Chemosphere. 61:259–266.
   PubMed Web of Science ®Google Scholar
• Logan BK, Mohr ALA, Friscia M, Krotulski AJ, Papsun DM, Kacinko SL, Ropero-Miller JD, Huestis MA. 2017. Reports of adverse events associated with use of Novel Psychoactive Substances, 2013–2016: a review. J Anal Toxicol. 41:573–610.
   PubMed Web of Science ®Google Scholar
• Longworth M, Connor M, Banister SD, Kassiou M. 2017. Synthesis and pharmacological profiling of the metabolites of synthetic cannabinoid drugs APICA, STS-135, ADB-PINACA, and 5F-ADB-PINACA. ACS Chem Neurosci. 8:1673–1680.
   PubMed Web of Science ®Google Scholar
• McGuinness D, Malikzay A, Visconti R, Lin K, Bayne M, Monsma F, Lunn CA. 2009. Characterizing cannabinoid CB2 receptor ligands using DiscoveRx PathHunter beta-arrestin assay. J Biomol Screen. 14:49–58.
   PubMed Web of Science ®Google Scholar
• Michelini E, Cevenini L, Mezzanotte L, Leskinen P, Virta M, Karp M, Roda A. 2008. A sensitive recombinant cell-based bioluminescent assay for detection of androgen-like compounds. Nat Protoc. 3:1895–1902.
   PubMed Web of Science ®Google Scholar
• Michelini E, Leskinen P, Virta M, Karp M, Roda A. 2005a. A new recombinant cell-based bioluminescent assay for sensitive androgen-like compound detection. Biosens Bioelectron. 20:2261–2267.
   PubMed Web of Science ®Google Scholar
• Michelini E, Magliulo M, Leskinen P, Virta M, Karp M, Roda A. 2005b. Recombinant cell-based bioluminescence assay for androgen bioactivity determination in clinical samples. Clin Chem. 51:1995–1998.
   PubMed Web of Science ®Google Scholar
• Mooney MH, Le Bizec B, Elliott CT. 2009. Combining biomarker screening and mass-spectrometric analysis to detect hormone abuse in cattle. Trends Anal Chem. 28:665–675.
   Web of Science ®Google Scholar
• Morgan DJ, Muller CH, Murataeva NA, Davis BJ, Mackie K. 2012. Delta9-tetrahydrocannabinol (Delta9-THC) attenuates mouse sperm motility and male fecundity. Br J Pharmacol. 165:2575–2583.
   PubMed Web of Science ®Google Scholar
• National Institute on Drug Abuse (NIDA). 2018. Steroids and Other Appearance and Performance Enhancing Drugs (APEDs).
   Google Scholar
• Nielen MW, Bovee TF, Heskamp HH, Lasaroms JJ, Sanders MB, Van Rhijn JA, Groot MJ, Hoogenboom LA. 2006. Screening for estrogen residues in calf urine: comparison of a validated yeast estrogen bioassay and gas chromatography-tandem mass spectrometry. Food Addit Contam. 23:1123–1131.
   PubMed Web of Science ®Google Scholar
• Nielen MW, Bovee TF, van Engelen MC, Rutgers P, Hamers AR, van Rhijn JH, Hoogenboom LR. 2006. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification. Anal Chem. 78:424–431.
   PubMed Web of Science ®Google Scholar
• Nielen MW, Elliott CT, Boyd SA, Courtheyn D, Essers ML, Hooijerink HH, van Bennekom EO, Fuchs RE. 2003. Identification of an unknown beta-agonist in feed by liquid chromatography/bioassay/quadrupole time-of-flight tandem mass spectrometry with accurate mass measurement. Rapid Commun Mass Spectrom. 17:1633–1641.
   PubMed Web of Science ®Google Scholar
• Nielen MW, van Bennekom EO, Heskamp HH, van Rhijn JH, Bovee TF, Hoogenboom LR. 2004. Bioassay-directed identification of estrogen residues in urine by liquid chromatography electrospray quadrupole time-of-flight mass spectrometry. Anal Chem. 76:6600–6608.
   PubMed Web of Science ®Google Scholar
• Noppe H, Le Bizec B, Verheyden K, De Brabander HF. 2008. Novel analytical methods for the determination of steroid hormones in edible matrices. Anal Chim Acta. 611:1–16.
   PubMed Web of Science ®Google Scholar
• Ojanpera I, Kolmonen M, Pelander A. 2012. Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control. Anal Bioanal Chem. 403:1203–1220.
   PubMed Web of Science ®Google Scholar
• Pasin D, Cawley A, Bidny S, Fu S. 2017. Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical review. Anal Bioanal Chem. 409:5821–5836.
   PubMed Web of Science ®Google Scholar
• Pathan H, Williams J. 2012. Basic opioid pharmacology: an update. Br J Pain. 6:11–16.
   PubMedGoogle Scholar
• Pinel G, Weigel S, Antignac J-P, Mooney MH, Elliott CT, Nielen MWF, Le Bizec B. 2010. Targeted and untargeted profiling of biological fluids to screen for anabolic practices in cattle. Trends Anal Chem. 29:1269–1280.
   Web of Science ®Google Scholar
• Pitardi D, Cini B, Paleologo M, Brouwer A, Behnisch P, van der Linden S, Vincenti M, Capra P, Gili M, Pezzolato M, et al. 2015. Effect-based detection of synthetic glucocorticoids in bovine urine. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 32:194–204.
   PubMed Web of Science ®Google Scholar
• Prekupec MP, Mansky PA, Baumann MH. 2017. Misuse of novel synthetic opioids: a deadly new trend. J Addict Med. 11:256–265.
   PubMed Web of Science ®Google Scholar
• Purohit V, Ahluwahlia BS, Vigersky RA. 1980. Marihuana inhibits dihydrotestosterone binding to the androgen receptor. Endocrinology. 107:848–850.
   PubMed Web of Science ®Google Scholar
• Raivio T, Palvimo JJ, Kannisto S, Voutilainen R, Janne OA. 2002. Transactivation assay for determination of glucocorticoid bioactivity in human serum. J Clin Endocrinol Metab. 87:3740–3744.
   PubMed Web of Science ®Google Scholar
• Raivio T, Santti H, Schatzl G, Gsur A, Haidinger G, Palvimo JJ, Janne OA, Madersbacher S. 2003. Reduced circulating androgen bioactivity in patients with prostate cancer. Prostate. 55:194–198.
   PubMed Web of Science ®Google Scholar
• Raivio T, Tapanainen JS, Kunelius P, Janne OA. 2002. Serum androgen bioactivity during 5alpha-dihydrotestosterone treatment in elderly men. J Androl. 23:919–921.
   PubMedGoogle Scholar
• Rajasekaran M, Brents LK, Franks LN, Moran JH, Prather PL. 2013. Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. Toxicol Appl Pharmacol. 269:100–108.
   PubMed Web of Science ®Google Scholar
• Roy P, Alevizaki M, Huhtaniemi I. 2008. In vitro bioassays for androgens and their diagnostic applications. Hum Reprod Update. 14:73–82.
   PubMed Web of Science ®Google Scholar
• Roy P, Franks S, Read M, Huhtaniemi IT. 2006. Determination of androgen bioactivity in human serum samples using a recombinant cell based in vitro bioassay. J Steroid Biochem Mol Biol. 101:68–77.
   PubMed Web of Science ®Google Scholar
• Roy P, Salminen H, Koskimies P, Simola J, Smeds A, Saukko P, Huhtaniemi IT. 2004. Screening of some anti-androgenic endocrine disruptors using a recombinant cell-based in vitro bioassay. J Steroid Biochem Mol Biol. 88:157–166.
   PubMed Web of Science ®Google Scholar
• Schumacher SB, Van den Hauwe O, Van Peteghem CH, Naegeli H. 2003. Development of a dual luciferase reporter screening assay for the detection of synthetic glucocorticoids in animal tissues. Analyst. 128:1406–1412.
   PubMed Web of Science ®Google Scholar
• Scippo M-L, Willemsen P, Danyi S, Helbo V, Muller M, Martial J, Maghuin-Rogister G. 2004. Receptor-based screening assays: new perspectives in anti-doping control. Chromatographia. 59:S23–S27.
   Web of Science ®Google Scholar
• Seely KA, Brents LK, Radominska-Pandya A, Endres GW, Keyes GS, Moran JH, Prather PL. 2012. A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptors. Chem Res Toxicol. 25:825–827.
   PubMed Web of Science ®Google Scholar
• Sohoni P, Sumpter JP. 1998. Several environmental oestrogens are also anti-androgens. J Endocrinol. 158:327–339.
   PubMed Web of Science ®Google Scholar
• Sonneveld E, Jansen HJ, Riteco JA, Brouwer A, van der Burg B. 2004. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays. Toxicol Sci. 83:136–148.
   PubMed Web of Science ®Google Scholar
• Thevis M, Schanzer W. 2018. Detection of SARMs in doping control analysis. Mol Cell Endocrinol. 464:34–45.
   PubMed Web of Science ®Google Scholar
• van der Lee MM, Blomenrohr M, van der Doelen AA, Wat JW, Smits N, Hanson BJ, van Koppen CJ, Zaman GJ. 2009. Pharmacological characterization of receptor redistribution and beta-arrestin recruitment assays for the cannabinoid receptor 1. J Biomol Screen. 14:811–823.
   PubMedGoogle Scholar
• Wiley JL, Marusich JA, Lefever TW, Antonazzo KR, Wallgren MT, Cortes RA, Patel PR, Grabenauer M, Moore KN, Thomas BF. 2015. AB-CHMINACA, AB-PINACA, and FUBIMINA: affinity and potency of novel synthetic cannabinoids in producing delta9-tetrahydrocannabinol-like effects in mice. J Pharmacol Exp Ther. 354:328–339.
   PubMed Web of Science ®Google Scholar
• Willemsen P, Scippo ML, Kausel G, Figueroa J, Maghuin-Rogister G, Martial JA, Muller M. 2004. Use of reporter cell lines for detection of endocrine-disrupter activity. Anal Bioanal Chem. 378:655–663.
   PubMed Web of Science ®Google Scholar
• Willemsen P, Scippo ML, Maghuin-Rogister G, Martial JA, Muller M. 2005. Enhancement of steroid receptor-mediated transcription for the development of highly responsive bioassays. Anal Bioanal Chem. 382:894–905.
   PubMed Web of Science ®Google Scholar
• Willemsen P, Scippo M-L, Maghuin-Rogister G, Martial JA, Muller M. 2002. Use of specific bioluminescent cell lines for the detection of steroid hormone (ant)agonists in meat producing animals. Anal Chim Acta. 473:119–126.
   Web of Science ®Google Scholar
• Wolf S, Diel P, Parr MK, Rataj F, Schanzer W, Vollmer G, Zierau O. 2011. Long-term detection of methyltestosterone (ab-) use by a yeast transactivation system. Arch Toxicol. 85:285–292.
   PubMed Web of Science ®Google Scholar
• Wolf S, Rataj F, Zierau O, Ostermann K, Diel P, Parr MK, Vollmer G, Rodel G. 2010. A novel combined approach to detect androgenic activities with yeast based assays in Schizosaccharomyces pombe and Saccharomyces cerevisiae. Toxicol Lett. 199:410–415.
   PubMed Web of Science ®Google Scholar
• World Anti-Doping Agency (WADA). 2018. The World Anti-Doping code International Standard: Prohibitited list Januari 2018. pp. 1–10.
   Google Scholar
• Yuan X, Forman BM. 2005. Detection of designer steroids. Nucl Recept Signal. 3:e002.
   PubMedGoogle Scholar
• Zawilska JB. 2017. An expanding world of novel psychoactive substances: opioids. Front Psychiatry. 8:110.
   PubMed Web of Science ®Google Scholar
• Zierau O, Lehmann S, Vollmer G, Schanzer W, Diel P. 2008. Detection of anabolic steroid abuse using a yeast transactivation system. Steroids. 73:1143–1147.
   PubMed Web of Science ®Google Scholar
• Zutz C, Wagener K, Yankova D, Eder S, Mostl E, Drillich M, Rychli K, Wagner M, Strauss J. 2017. A robust high-throughput fungal biosensor assay for the detection of estrogen activity. Steroids. 126:57–65.
   PubMed Web of Science ®Google Scholar